HomeAI · summaries
Storia in 18 fonti
La retatrutida de Eli Lilly reduce la obesidad en un 30% a los dos a�os de tratamiento
Los resultados preliminares del estudio TRIUMPH-1 confirman resultados anteriores en fase II de la retatrutida (LY3437943), f�rmaco en fase experimental de la familia de los GLP-1...
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Retatrutide induces ‘impressive’ weight loss of up to 28.3% for adults with obesity
A once-weekly triple receptor agonist conferred up to 28.3% weight loss at 80 weeks for adults with overweight or obesity, according to topline results from a phase 3 trial. As…
- ·
nbcnews.com
People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says
The results — the most weight loss ever seen in a medication trial — put the drug’s effectiveness on par with bariatric surgery.
